Skip to main content
. 2022 Jun 6;18(1):226–232. doi: 10.4103/1673-5374.344841

Figure 7.

Figure 7

Effects of different BR formulations on expression levels of apoptotic proteins Bax and Bcl-2 in hippocampal tissue of a mouse model of AD-like Aβ neurotoxicity.

(A) Western blotting of Bax and Bcl-2. β-Actin was an internal reference. (B, C) Quantitative results of relative expression levels of apoptotic proteins Bcl-2 (B) and Bax (C). Data are expressed as the mean ± SD (n = 3). ##P < 0.01, vs. sham group; *P < 0.05, **P < 0.01, vs. model group; †P < 0.05, ††P < 0.01 (one-way analysis of variance followed by LSD post hoc test). AD: Alzheimer’s disease; Aβ: amyloid-β protein; BR: berberine hydrochloride; BR-S: BR solution; BR-CL: BR common nanoliposomes; BR-PL: BR PEGylated nanoliposomes; BR-Lf: BR PEGylated nanoliposomes with lactoferrin modified.